---
layout: post
title: "E11A Pediatric Extrapolation; International Council for Harmonisation; Draft Guidance for Industry; Availability"
date: 2026-02-05 19:00:30 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-18517
original_published: 2022-08-29 00:00:00 +0000
significance: 8.00
---

# E11A Pediatric Extrapolation; International Council for Harmonisation; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** August 29, 2022 00:00 UTC
**Document Number:** 2022-18517

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "E11A Pediatric Extrapolation." The draft guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The draft guidance provides a comprehensive and systematic approach to the use of pediatric extrapolation during drug development. The draft guidance also discusses study designs and statistical methodologies, including modeling and simulation, that can be utilized to develop and implement a pediatric extrapolation approach. The draft guidance is intended to provide recommendations for the use of pediatric extrapolation during drug development, which, when used appropriately, can increase the efficiency of pediatric drug development and accelerate the availability of safe and effective drugs approved for use in children.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/08/29/2022-18517/e11a-pediatric-extrapolation-international-council-for-harmonisation-draft-guidance-for-industry)
- API: https://www.federalregister.gov/api/v1/documents/2022-18517

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
